{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:39:09Z","timestamp":1784547549509,"version":"3.55.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004391","name":"China Medical University Hospital","doi-asserted-by":"publisher","award":["C1110812016"],"award-info":[{"award-number":["C1110812016"]}],"id":[{"id":"10.13039\/501100004391","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004391","name":"China Medical University Hospital","doi-asserted-by":"publisher","award":["C1110812016-9"],"award-info":[{"award-number":["C1110812016-9"]}],"id":[{"id":"10.13039\/501100004391","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004391","name":"China Medical University Hospital","doi-asserted-by":"publisher","award":["DMR 114-175"],"award-info":[{"award-number":["DMR 114-175"]}],"id":[{"id":"10.13039\/501100004391","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010002","name":"Ministry of Education","doi-asserted-by":"publisher","award":["Yu Shan Scholar award"],"award-info":[{"award-number":["Yu Shan Scholar award"]}],"id":[{"id":"10.13039\/100010002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["NSTC 112-2314-B-039-004"],"award-info":[{"award-number":["NSTC 112-2314-B-039-004"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-26312-6","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T13:53:34Z","timestamp":1764165214000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Elevated Lactobacillus salivarius and genus Akkermansia in fecal samples of Taiwanese patients with parkinson\u2019s disease and diabetes mellitus"],"prefix":"10.1038","volume":"15","author":[{"given":"Sheng-Ta","family":"Tsai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Lun","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Kuei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Walther-Antonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Yao","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dy-San","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Yang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Vettleson-Trutza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Chun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Chu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Ren","family":"Hsueh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Der-Yang","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chon-Haw","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"key":"26312_CR1","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/978-94-007-5416-4_16","volume":"65","author":"TR Mhyre","year":"2012","unstructured":"Mhyre, T. R., Boyd, J. T., Hamill, R. W. & Maguire-Zeiss, K. A. Parkinson\u2019s disease. Subcell. Biochem. 65, 389\u2013455 (2012).","journal-title":"Subcell. Biochem."},{"key":"26312_CR2","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.3171\/2020.10.JNS202277","volume":"135","author":"WS Gibson","year":"2021","unstructured":"Gibson, W. S. et al. Symptom-specific differential motor network modulation by deep brain stimulation in parkinson\u2019s disease. J. Neurosurg. 135, 1771\u20131779 (2021).","journal-title":"J. Neurosurg."},{"key":"26312_CR3","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/s41582-022-00681-2","volume":"18","author":"AH Tan","year":"2022","unstructured":"Tan, A. H., Lim, S. Y. & Lang, A. E. The microbiome\u2013gut\u2013brain axis in Parkinson disease \u2014 from basic research to the clinic. Nat. Rev. Neurol. 18, 476\u2013495 (2022).","journal-title":"Nat. Rev. Neurol."},{"key":"26312_CR4","doi-asserted-by":"publisher","first-page":"e5921","DOI":"10.1097\/MD.0000000000005921","volume":"96","author":"YW Yang","year":"2017","unstructured":"Yang, Y. W. et al. Increased risk of Parkinson disease with diabetes mellitus in a population-based study. Med. (Baltim). 96, e5921 (2017).","journal-title":"Med. (Baltim)."},{"key":"26312_CR5","doi-asserted-by":"publisher","first-page":"107026","DOI":"10.1016\/j.parkreldis.2024.107026","volume":"125","author":"N Grotewold","year":"2024","unstructured":"Grotewold, N. & Albin, R. L. Update: Protective and risk factors for Parkinson disease. Parkinsonism Relat. Disord. 125, 107026 (2024).","journal-title":"Parkinsonism Relat. Disord"},{"key":"26312_CR6","doi-asserted-by":"publisher","first-page":"e3549","DOI":"10.1097\/MD.0000000000003549","volume":"95","author":"X Yue","year":"2016","unstructured":"Yue, X. et al. Risk of Parkinson disease in diabetes mellitus: An updated meta-analysis of population-based cohort studies. Med. (Baltim). 95, e3549 (2016).","journal-title":"Med. (Baltim)."},{"key":"26312_CR7","doi-asserted-by":"publisher","first-page":"842","DOI":"10.2337\/dc06-2011","volume":"30","author":"G Hu","year":"2007","unstructured":"Hu, G., Jousilahti, P., Bidel, S., Antikainen, R. & Tuomilehto, J. Type 2 diabetes and the risk of parkinson\u2019s disease. Diabetes Care. 30, 842\u2013847 (2007).","journal-title":"Diabetes Care"},{"key":"26312_CR8","doi-asserted-by":"publisher","first-page":"110672","DOI":"10.1016\/j.brainresbull.2023.110672","volume":"199","author":"C Dai","year":"2023","unstructured":"Dai, C. et al. Glucose metabolism impairment in parkinson\u2019s disease. Brain Res. Bull. 199, 110672 (2023).","journal-title":"Brain Res. Bull."},{"key":"26312_CR9","doi-asserted-by":"publisher","first-page":"682","DOI":"10.3389\/fnins.2020.00682","volume":"14","author":"Y Kong","year":"2020","unstructured":"Kong, Y. et al. Elucidating the relationship between diabetes mellitus and parkinson\u2019s disease using 18F-FP-(+)-DTBZ, a positron-emission tomography probe for vesicular monoamine transporter 2. Front. Neurosci. 14, 682 (2020).","journal-title":"Front. Neurosci."},{"key":"26312_CR10","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1056\/NEJMoa2312323","volume":"390","author":"WG Meissner","year":"2024","unstructured":"Meissner, W. G. et al. Trial of lixisenatide in early parkinson\u2019s disease. N Engl. J. Med. 390, 1176\u20131185 (2024).","journal-title":"N Engl. J. Med."},{"key":"26312_CR11","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1056\/NEJMoa1509225","volume":"373","author":"MA Pfeffer","year":"2015","unstructured":"Pfeffer, M. A. et al. Lixisenatide in patients with type 2 diabetes and acute coronary syndrome. N Engl. J. Med. 373, 2247\u20132257 (2015).","journal-title":"N Engl. J. Med."},{"key":"26312_CR12","doi-asserted-by":"publisher","first-page":"e029282","DOI":"10.1161\/JAHA.122.029282","volume":"12","author":"ED Michos","year":"2023","unstructured":"Michos, E. D., Lopez-Jimenez, F. & Gulati, M. Role of glucagon\u2010like peptide\u20101 receptor agonists in achieving weight loss and improving cardiovascular outcomes in people with overweight and obesity. J. Am. Heart Assoc. 12, e029282 (2023).","journal-title":"J. Am. Heart Assoc."},{"key":"26312_CR13","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.drudis.2016.01.013","volume":"21","author":"D Athauda","year":"2016","unstructured":"Athauda, D. & Foltynie, T. The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in parkinson\u2019s disease: Mechanisms of action. Drug Discov Today. 21, 802\u2013818 (2016).","journal-title":"Drug Discov Today"},{"key":"26312_CR14","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.3390\/ijms25073812","volume":"25","author":"K Kalinderi","year":"2024","unstructured":"Kalinderi, K., Papaliagkas, V. & Fidani, L. GLP-1 receptor agonists: A new treatment in parkinson\u2019s disease. Int. J. Mol. Sci. 25, 3812 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"26312_CR15","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"AJ Hughes","year":"1992","unstructured":"Hughes, A. J., Daniel, S. E., Kilford, L. & Lees, A. J. Accuracy of clinical diagnosis of idiopathic parkinson\u2019s disease: A clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry. 55, 181\u2013184 (1992).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"26312_CR16","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","volume":"37","author":"E Bolyen","year":"2019","unstructured":"Bolyen, E. et al. Reproducible, interactive, scalable and extensible Microbiome data science using QIIME 2. Nat. Biotechnol. 37, 852\u2013857 (2019).","journal-title":"Nat. Biotechnol."},{"key":"26312_CR17","doi-asserted-by":"publisher","first-page":"e1009581","DOI":"10.1371\/journal.pcbi.1009581","volume":"17","author":"MSII Robeson","year":"2021","unstructured":"Robeson, M. S. I. I. et al. RESCRIPt: Reproducible sequence taxonomy reference database management. PLoS Comput. Biol. 17, e1009581 (2021).","journal-title":"PLoS Comput. Biol."},{"key":"26312_CR18","doi-asserted-by":"publisher","first-page":"D590","DOI":"10.1093\/nar\/gks1219","volume":"41","author":"C Quast","year":"2013","unstructured":"Quast, C. et al. The SILVA ribosomal RNA gene database project: Improved data processing and web-based tools. Nucleic Acids Res. 41, D590\u2013596 (2013).","journal-title":"Nucleic Acids Res."},{"key":"26312_CR19","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/s41598-023-27555-x","volume":"13","author":"AE Asangba","year":"2023","unstructured":"Asangba, A. E. et al. Diagnostic and prognostic potential of the Microbiome in ovarian cancer treatment response. Sci. Rep. 13, 730 (2023).","journal-title":"Sci. Rep."},{"key":"26312_CR20","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1093\/bioinformatics\/btv183","volume":"31","author":"BJ Kelly","year":"2015","unstructured":"Kelly, B. J. et al. Power and sample-size Estimation for Microbiome studies using pairwise distances and PERMANOVA. Bioinformatics 31, 2461\u20132468 (2015).","journal-title":"Bioinformatics"},{"key":"26312_CR21","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1080\/01621459.1952.10483441","volume":"47","author":"WH Kruskal","year":"1952","unstructured":"Kruskal, W. H. & Wallis, W. A. Use of ranks in one-criterion variance analysis. J. Am. Stat. Assoc. 47, 583\u2013621 (1952).","journal-title":"J. Am. Stat. Assoc."},{"key":"26312_CR22","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1093\/jee\/39.2.269","volume":"39","author":"F Wilcoxon","year":"1946","unstructured":"Wilcoxon, F. Individual comparisons of grouped data by ranking methods. J. Econ. Entomol. 39, 269\u2013270 (1946).","journal-title":"J. Econ. Entomol."},{"key":"26312_CR23","doi-asserted-by":"publisher","first-page":"R60","DOI":"10.1186\/gb-2011-12-6-r60","volume":"12","author":"N Segata","year":"2011","unstructured":"Segata, N. et al. Metagenomic biomarker discovery and explanation. Genome Biol. 12, R60 (2011).","journal-title":"Genome Biol."},{"key":"26312_CR24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41531-024-00681-7","volume":"10","author":"D Kwon","year":"2024","unstructured":"Kwon, D. et al. Diet and the gut Microbiome in patients with parkinson\u2019s disease. Npj Parkinsons Dis. 10, 89 (2024).","journal-title":"Npj Parkinsons Dis."},{"key":"26312_CR25","doi-asserted-by":"publisher","first-page":"943427","DOI":"10.3389\/fcimb.2022.943427","volume":"12","author":"G Letchumanan","year":"2022","unstructured":"Letchumanan, G. et al. Gut microbiota composition in prediabetes and newly diagnosed type 2 diabetes: A systematic review of observational studies. Front. Cell. Infect. Microbiol. 12, 943427 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"26312_CR26","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1111\/jam.13111","volume":"120","author":"E Nistal","year":"2016","unstructured":"Nistal, E. et al. Study of duodenal bacterial communities by 16S rRNA gene analysis in adults with active Celiac disease vs non-celiac disease controls. J. Appl. Microbiol. 120, 1691\u20131700 (2016).","journal-title":"J. Appl. Microbiol."},{"key":"26312_CR27","doi-asserted-by":"publisher","first-page":"e0176555","DOI":"10.1371\/journal.pone.0176555","volume":"12","author":"DE Almonacid","year":"2017","unstructured":"Almonacid, D. E. et al. 16S rRNA gene sequencing and healthy reference ranges for 28 clinically relevant microbial taxa from the human gut Microbiome. PLoS One. 12, e0176555 (2017).","journal-title":"PLoS One"},{"key":"26312_CR28","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1128\/AEM.01687-10","volume":"77","author":"EJ Raftis","year":"2011","unstructured":"Raftis, E. J., Salvetti, E., Torriani, S., Felis, G. E. & O\u2019Toole, P. W. Genomic diversity of Lactobacillus salivarius. Appl. Environ. Microbiol. 77, 954\u2013965 (2011).","journal-title":"Appl. Environ. Microbiol."},{"key":"26312_CR29","doi-asserted-by":"publisher","first-page":"969","DOI":"10.3389\/fimmu.2019.00969","volume":"10","author":"L Magistrelli","year":"2019","unstructured":"Magistrelli, L. et al. Probiotics May have beneficial effects in parkinson\u2019s disease: In vitro evidence. Front. Immunol. 10, 969 (2019).","journal-title":"Front. Immunol."},{"key":"26312_CR30","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41467-019-08294-y","volume":"10","author":"SP van Kessel","year":"2019","unstructured":"van Kessel, S. P. et al. Gut bacterial tyrosine decarboxylases restrict levels of Levodopa in the treatment of parkinson\u2019s disease. Nat. Commun. 10, 310 (2019).","journal-title":"Nat. Commun."},{"key":"26312_CR31","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.clnu.2013.02.007","volume":"32","author":"N Larsen","year":"2013","unstructured":"Larsen, N. et al. Effect of Lactobacillus salivarius Ls-33 on fecal microbiota in obese adolescents. Clin. Nutr. 32, 935\u2013940 (2013).","journal-title":"Clin. Nutr."},{"key":"26312_CR32","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/S0140-6736(08)60207-X","volume":"371","author":"MG Besselink","year":"2008","unstructured":"Besselink, M. G. et al. Probiotic prophylaxis in predicted severe acute pancreatitis: A randomised, double-blind, placebo-controlled trial. Lancet 371, 651\u2013659 (2008).","journal-title":"Lancet"},{"key":"26312_CR33","doi-asserted-by":"publisher","first-page":"S371","DOI":"10.3233\/JPD-191802","volume":"9","author":"T Van Laar","year":"2019","unstructured":"Van Laar, T., Boertien, J. M. & Herranz, A. H. Faecal transplantation, pro- and prebiotics in parkinson\u2019s disease: Hope or hype? J. Parkinsons Dis. 9, S371\u2013S379 (2019).","journal-title":"J. Parkinsons Dis."},{"key":"26312_CR34","doi-asserted-by":"publisher","first-page":"1007654","DOI":"10.3389\/fphar.2022.1007654","volume":"13","author":"L Xie","year":"2022","unstructured":"Xie, L., Chen, D., Zhu, X. & Cheng, C. Efficacy and safety of probiotics in parkinson\u2019s constipation: A systematic review and meta-analysis. Front. Pharmacol. 13, 1007654 (2022).","journal-title":"Front. Pharmacol."},{"key":"26312_CR35","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature12198","volume":"498","author":"FH Karlsson","year":"2013","unstructured":"Karlsson, F. H. et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498, 99\u2013103 (2013).","journal-title":"Nature"},{"key":"26312_CR36","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/j.clnu.2018.08.009","volume":"38","author":"S Sabico","year":"2019","unstructured":"Sabico, S. et al. Effects of a 6-month multi-strain probiotics supplementation in endotoxemic, inflammatory and cardiometabolic status of T2DM patients: A randomized, double-blind, placebo-controlled trial. Clin. Nutr. 38, 1561\u20131569 (2019).","journal-title":"Clin. Nutr."},{"key":"26312_CR37","doi-asserted-by":"publisher","first-page":"e001028","DOI":"10.1136\/bmjdrc-2019-001028","volume":"8","author":"PS Hsieh","year":"2020","unstructured":"Hsieh, P. S. et al. Lactobacillus salivarius AP-32 and Lactobacillus reuteri GL-104 decrease glycemic levels and attenuate diabetes-mediated liver and kidney injury in db\/db mice. BMJ Open. Diabetes Res. Care. 8, e001028 (2020).","journal-title":"BMJ Open. Diabetes Res. Care"},{"key":"26312_CR38","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1099\/ijs.0.02873-0","volume":"54","author":"M Derrien","year":"2004","unstructured":"Derrien, M., Vaughan, E. E., Plugge, C. M. & de Vos, W. M. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int. J. Syst. Evol. Microbiol. 54, 1469\u20131476 (2004).","journal-title":"Int. J. Syst. Evol. Microbiol."},{"key":"26312_CR39","doi-asserted-by":"publisher","first-page":"9066","DOI":"10.1073\/pnas.1219451110","volume":"110","author":"A Everard","year":"2013","unstructured":"Everard, A. et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl. Acad. Sci. USA. 110, 9066\u20139071 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"26312_CR40","doi-asserted-by":"publisher","first-page":"e0142164","DOI":"10.1371\/journal.pone.0142164","volume":"10","author":"S Hasegawa","year":"2015","unstructured":"Hasegawa, S. et al. Intestinal dysbiosis and Lowered serum lipopolysaccharide-binding protein in parkinson\u2019s disease. PLoS One. 10, e0142164 (2015).","journal-title":"PLoS One"},{"key":"26312_CR41","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41531-021-00156-z","volume":"7","author":"S Romano","year":"2021","unstructured":"Romano, S. et al. Meta-analysis of the parkinson\u2019s disease gut Microbiome suggests alterations linked to intestinal inflammation. Npj Parkinsons Dis. 7, 27 (2021).","journal-title":"Npj Parkinsons Dis."},{"key":"26312_CR42","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1002\/mds.28119","volume":"35","author":"H Nishiwaki","year":"2020","unstructured":"Nishiwaki, H. et al. Meta-analysis of gut dysbiosis in parkinson\u2019s disease. Mov. Disord. 35, 1626\u20131635 (2020).","journal-title":"Mov. Disord"},{"key":"26312_CR43","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41531-022-00328-5","volume":"8","author":"H Nishiwaki","year":"2022","unstructured":"Nishiwaki, H. et al. Short chain fatty acids-producing and mucin-degrading intestinal bacteria predict the progression of early parkinson\u2019s disease. Npj Parkinsons Dis. 8, 65 (2022).","journal-title":"Npj Parkinsons Dis."},{"key":"26312_CR44","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2174\/1871530316666160831093813","volume":"16","author":"M Remely","year":"2016","unstructured":"Remely, M. et al. Gut microbiota of obese, type 2 diabetic individuals is enriched in Faecalibacterium prausnitzii, Akkermansia muciniphila and Peptostreptococcus anaerobius after weight loss. Endocr. Metab. Immune Disord Drug Targets. 16, 99\u2013106 (2016).","journal-title":"Endocr. Metab. Immune Disord Drug Targets"},{"key":"26312_CR45","doi-asserted-by":"publisher","first-page":"e2100536","DOI":"10.1002\/advs.202100536","volume":"8","author":"J Zhang","year":"2021","unstructured":"Zhang, J. et al. Decreased abundance of Akkermansia muciniphila leads to the impairment of insulin secretion and glucose homeostasis in lean type 2 diabetes. Adv. Sci. (Weinh). 8, e2100536 (2021).","journal-title":"Adv. Sci. (Weinh)"},{"key":"26312_CR46","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40478-015-0196-0","volume":"3","author":"T Clairembault","year":"2015","unstructured":"Clairembault, T. et al. Structural alterations of the intestinal epithelial barrier in parkinson\u2019s disease. Acta Neuropathol. Commun. 3, 12 (2015).","journal-title":"Acta Neuropathol. Commun."},{"key":"26312_CR47","doi-asserted-by":"crossref","unstructured":"Geerlings, S. Y., Kostopoulos, I., de Vos, W. M., Belzer, C. & Microorganisms Akkermansia muciniphila in the human gastrointestinal tract: When, where, and how? 6:75. (2018).","DOI":"10.3390\/microorganisms6030075"},{"key":"26312_CR48","doi-asserted-by":"publisher","first-page":"69","DOI":"10.15605\/jafes.037.01.13","volume":"37","author":"MID Sanjiwani","year":"2022","unstructured":"Sanjiwani, M. I. D., Aryadi, I. P. H. & Semadi, I. M. S. Review of literature on Akkermansia muciniphila and its possible role in the etiopathogenesis and therapy of type 2 diabetes mellitus. J. ASEAN Fed. Endocr. Soc. 37, 69\u201374 (2022).","journal-title":"J. ASEAN Fed. Endocr. Soc."},{"key":"26312_CR49","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/s41591-019-0495-2","volume":"25","author":"C Depommier","year":"2019","unstructured":"Depommier, C. et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: A proof-of-concept exploratory study. Nat. Med. 25, 1096\u20131103 (2019).","journal-title":"Nat. Med."},{"key":"26312_CR50","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/nature15766","volume":"528","author":"K Forslund","year":"2015","unstructured":"Forslund, K. et al. Disentangling type 2 diabetes and Metformin treatment signatures in the human gut microbiota. Nature 528, 262\u2013266 (2015).","journal-title":"Nature"},{"key":"26312_CR51","doi-asserted-by":"publisher","first-page":"5935","DOI":"10.1128\/AEM.01357-14","volume":"80","author":"H Lee","year":"2014","unstructured":"Lee, H. & Ko, G. Effect of Metformin on metabolic improvement and gut microbiota. Appl. Environ. Microbiol. 80, 5935\u20135943 (2014).","journal-title":"Appl. Environ. Microbiol."},{"key":"26312_CR52","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1136\/gutjnl-2012-303839","volume":"63","author":"NR Shin","year":"2014","unstructured":"Shin, N. R. et al. An increase in the Akkermansia spp. Population induced by Metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut 63, 727\u2013735 (2014).","journal-title":"Gut"},{"key":"26312_CR53","doi-asserted-by":"publisher","first-page":"54","DOI":"10.2337\/dc16-1324","volume":"40","author":"J de la Cuesta-Zuluaga","year":"2017","unstructured":"de la Cuesta-Zuluaga, J. et al. Metformin is associated with higher relative abundance of mucin-degrading Akkermansia muciniphila and several short-chain fatty acid-producing microbiota in the gut. Diabetes Care. 40, 54\u201362 (2017).","journal-title":"Diabetes Care"},{"key":"26312_CR54","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3389\/fimmu.2019.00239","volume":"10","author":"J Campos-Acu\u00f1a","year":"2019","unstructured":"Campos-Acu\u00f1a, J., Elgueta, D. & Pacheco, R. T-cell-driven inflammation as a mediator of the gut-brain axis involved in parkinson\u2019s disease. Front. Immunol. 10, 239 (2019).","journal-title":"Front. Immunol."},{"key":"26312_CR55","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1007\/s40618-023-02250-w","volume":"47","author":"C Knott-Torcal","year":"2024","unstructured":"Knott-Torcal, C. et al. Quantitative analysis of Tr1 lymphocytes in patients with type 2 diabetes mellitus. J. Endocrinol. Invest. 47, 1447\u20131455 (2024).","journal-title":"J. Endocrinol. Invest."},{"key":"26312_CR56","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1002\/jcb.25376","volume":"117","author":"M Ramalingam","year":"2016","unstructured":"Ramalingam, M. & Kim, S. J. The neuroprotective role of insulin against MPP(+) -induced parkinson\u2019s disease in differentiated SH-SY5Y cells. J. Cell. Biochem. 117, 917\u2013926 (2016).","journal-title":"J. Cell. Biochem."},{"key":"26312_CR57","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3389\/fimmu.2017.00754","volume":"8","author":"F Fransen","year":"2017","unstructured":"Fransen, F. et al. The impact of gut microbiota on gender-specific differences in immunity. Front. Immunol. 8, 754 (2017).","journal-title":"Front. Immunol."},{"key":"26312_CR58","doi-asserted-by":"publisher","first-page":"1124704","DOI":"10.3389\/fimmu.2023.1124704","volume":"14","author":"ZH Mao","year":"2023","unstructured":"Mao, Z. H., Gao, Z. X., Liu, D. W., Liu, Z. S. & Wu, P. Gut microbiota and its metabolites - molecular mechanisms and management strategies in diabetic kidney disease. Front. Immunol. 14, 1124704 (2023).","journal-title":"Front. Immunol."},{"key":"26312_CR59","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S1474-4422(23)00124-2","volume":"22","author":"D Berg","year":"2023","unstructured":"Berg, D. & Klein, C. \u03b1-synuclein seed amplification and its uses in parkinson\u2019s disease. Lancet Neurol. 22, 369\u2013371 (2023).","journal-title":"Lancet Neurol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26312-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26312-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26312-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T15:03:49Z","timestamp":1764169429000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26312-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["26312"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-26312-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"21 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42261"}}